Plain-English translation of NCT06189755 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for tiny molecules in blood called microRNAs that could serve as biomarkers—measurable signs—of obstructive sleep apnea. This study will collect blood samples from 500 people with moderate-to-severe sleep apnea and people without sleep apnea to see if microRNA patterns can help doctors identify the condition and predict who will benefit most from breathing treatment devices.
Currently, doctors have limited ways to identify sleep apnea or predict how well treatment will work for individual patients. Finding reliable biomarkers could make diagnosis easier, help monitor whether treatment is working, and show doctors which patients are most likely to benefit from specific therapies.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will likely have a sleep study to measure your sleep apnea severity, and researchers will collect blood samples to analyze your microRNA patterns. Your participation helps build a larger database that could improve how doctors identify and treat sleep apnea in the future. The exact number and timing of visits will be explained during enrollment.
AI-generated summary from trial data · Aug 13, 2026 · Not medical advice
United States
Iceland